F. Furlanello et al., CARDIAC-ARREST AND SUDDEN-DEATH IN COMPETITIVE ATHLETES WITH ARRHYTHMOGENIC RIGHT-VENTRICULAR DYSPLASIA, PACE, 21(1), 1998, pp. 331-335
Arrhythmogenic right ventricular dysplasia (ARVD) is a predisposing fa
ctor for sport-related cardiac arrest (CA), sudden cardiac death (SD).
and life-threatening ventricular tachyarrhythmias (VT). The aim of th
is study was the assessment of athletes with ARVD, particularly the CA
survivors. From 1974 to January 1996, 1642 competitive athletes (aver
. 25.5 yr.), 136 of whom were top level athletes (TLA), were studied f
or important arrhythmic manifestations. All athletes underwent an indi
vidualised study protocol including a series of non invasive and invas
ive diagnostic techniques. One hundred and one athletes (90 males, 11
females, aver. 25.9 yr.) were diagnosed as being affected by ARVD on t
he basis of the WHO/ISFC criteria. The same percentage (about 6%) of A
RVD is present in both the general arrhythmic athletes population and
in the subgroup of TLA. Prevalence of ARVD among athletes with CA or S
D is high (respectively 23% and 25%), confirming the observation that
ARVD is one of the major causes of SD in Italian athletes All CA were
athletic activity related, indicating the potentiality of of exercise
as a cause of electrical destabilisation in subjects with ARVD. In ath
letes with documented ARVD intense sport activity has to be proscribed
. In athletes at risk of CA or SD an aggressive treatment, ICD implant
ation and RF catheter ablation must be taken into consideration.